Torbjörn Karlsson

Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Nylund, Patrick; Garrido-Zabala, Berta; Tziola, Stefania Iliana; Mohajershojai, Tabassom et al.

Part of Blood Advances, p. 4825-4841, 2025

• DOI for Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma
• Download full text (pdf) of Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Vikman, Sofia; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, 2023

• DOI for Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia
• Download full text (pdf) of Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, 2023

• DOI for Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
• Download full text (pdf) of Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Part of Acta Haematologica, p. 326-333, 2022

• DOI for Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Larsson, Karin; Höglund, Martin; Larsson, Anders; Thulin, Måns et al.

Part of Growth Factors, p. 189-196, 2021

• DOI for Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia
• Download full text (pdf) of Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Nylund, Patrick; Garrido-Zabala, Berta; Tziola, Stefania Iliana; Mohajershojai, Tabassom et al.

Part of Blood Advances, p. 4825-4841, 2025

• DOI for Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma
• Download full text (pdf) of Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Vikman, Sofia; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, 2023

• DOI for Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia
• Download full text (pdf) of Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, 2023

• DOI for Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
• Download full text (pdf) of Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Part of Acta Haematologica, p. 326-333, 2022

• DOI for Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Larsson, Karin; Höglund, Martin; Larsson, Anders; Thulin, Måns et al.

Part of Growth Factors, p. 189-196, 2021

• DOI for Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia
• Download full text (pdf) of Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type

Larsson, Anders; Gåfvels, Mats; Karlsson, Torbjörn

Part of Case Reports in Oncology, p. 680-682, 2020

• DOI for Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type
• Download full text (pdf) of Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type

Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Karlsson, Torbjörn; Cherif, Honar

Part of Upsala Journal of Medical Sciences, p. 153-157, 2018

• DOI for Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital
• Download full text (pdf) of Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients

Karlsson, Torbjörn

Part of Journal of Inflammation, 2017

• DOI for Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients
• Download full text (pdf) of Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients

Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Karlsson, Torbjörn; Cherif, Honar

Part of Hematology Reports, 2016

• DOI for Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia
• Download full text (pdf) of Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital

Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, p. 257-262, 2015

• DOI for Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Hedenus, Michael; Karlsson, Torbjörn; Ludwig, Heinz; Rzychon, Beate et al.

Part of Medical Oncology, p. 302, 2014

• DOI for Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
• Download full text (pdf) of Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

Cherif, Honar; Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, p. 350-353, 2014

• DOI for Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Hjorth, Martin; Hjertner, Oyvind; Knudsen, Lene Meldgaard; Gulbrandsen, Nina et al.

Part of European Journal of Haematology, p. 485-496, 2012

• DOI for Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Waage, Anders; Gimsing, Peter; Fayers, Peter; Abildgaard, Niels et al.

Part of Blood, p. 1405-1412, 2010

• DOI for Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

The lncRNA PCAT1 recruits the Polycomb repressive complex 2 to target genomic regions and induce H3K27me3-mediated gene silencing in multiple myeloma

Garrido-Zabala, Berta; Tziola, Stefania Iliana; Nylund, Patrick; Karlsson, Torbjörn et al.